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MINI ABSTRACT: 
We conducted a meta-analysis and systematic review of randomized controlled trials, comparing 
suture cruroplasty versus prosthetic hiatal herniorrhpahy for large hiatus hernia, to determine the 
clinical outcomes, safety and effectiveness of these two methods. Four RCT between 1991 and 2014 
totaling 406 patients (Suture=186, Prosthesis=220) were analyzed and results presented.  
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STRUCTURED ABSTRACT: 
Aims and objective: The aim was to conduct a meta-analysis of RCTs comparing two methods of 
hiatal closure for large hiatal hernia and to evaluate their strengths and flaws. 
 
Material and Methods: Prospective RCTs comparing suture cruroplasty versus prosthetic hiatal 
herniorrhaphy for large hiatal hernia were selected by searching PubMed, Medline, Embase, Science 
Citation Index, Current Contents, and the Cochrane Central Register of Controlled Trials published 
between January 1991 and October 2014.The outcome variables analyzed included operating time, 
complications, recurrence of hiatal hernia or wrap migration and reoperation. These outcomes were 
unanimously decided to be important since they influence the practical approach towards patient 
management. Random effects model was used to calculate the effect size of both dichotomous and 
continuous data. Heterogeneity amongst the outcome variables of these trials was determined by the 
Cochran’s Q statistic and I2 index. The meta-analysis was prepared in accordance with PRISMA 
guidelines.  
 
Results: Four RCTs were analyzed totaling 406 patients (Suture=186, Prosthesis=220). For only one 
of the four outcomes i.e. reoperation rate (OR 3.73, 95% CI 1.18, 11.82, p=0.03) the pooled effect 
size favored prosthetic hiatal herniorrhaphy over suture cruroplasty. For other outcomes, comparable 
effect sizes were noted for both groups which included recurrence of hiatal hernia or wrap migration 
(OR 2.01, 95% CI 0.92, 4.39, p=0.07), operating time (SMD -0.46, 95% CI -1.16, -0.24, p=0.19) and 
complication rates (OR 1.06, 95% CI 0.45, 2.50, p=0.90).  
 
Conclusions: On the basis of our meta-analysis and its limitations, we believe that the prosthetic 
hiatal herniorrhaphy and suture cruroplasty produces comparable results for repair of large hiatal 
hernias. In the future a number of issues need to be addressed to determine the clinical outcomes, 
safety and effectiveness of these two methods for elective surgical treatment of large hiatal hernias.  
Presently the use of prosthetic hiatal herniorrhaphy for large hiatal hernia cannot be endorsed 
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routinely and the decision for the placement of mesh needs to be individualized based on the operative 
findings and the surgeon’s recommendation.  
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INTRODUCTION: 
Since the introduction of laparoscopic antireflux surgery in 19911, the repair of very large hiatal 
hernias, now encountered in approximately 50% of laparoscopic antireflux surgical practice2, seems to 
pose a challenging predicament for surgeons. In the chronic setting there is debate about indication for 
surgery and what is the best operative approach. The issue of which technique i.e. laparoscopic, 
transthoracic or transabdominal produces better surgical outcomes for these large hiatal hernia 
remains contentious. This is because all these three techniques seem to produce more or less 
equivalent results3. Furthermore there also remains a debate regarding the best way to close the crural 
pillars of these large hiatal hernias. This is because their repair is technically demanding and the 
traditional suture cruroplasty which is utilized to close hiatal defects is believed to yield a high 
recurrence rate. The dehiscence of crural repair therefore may lead to intrathoracic migration of the 
wrap. This may result in either acute hiatal hernia requiring emergent surgery or recurrence of reflux 
and/or dysphagia over a period of time requiring difficult revisional surgery. A number of studies 
analyzing laparoscopic repair of very large paraesophageal hiatal hernias by x-ray or endoscopy 
reveal between 12% to 42% failure rate due to disruption of the hiatal hernia repair suggesting 
significant room for improvement4,5. Furthermore there remains the debate regarding indications for 
surgery. 
 
As the diaphragm is under repetitive stress during respiratory ( breathing, sneezing and coughing) and 
non-respiratory functions (expulsion of vomit, feces, and urine, laughing and preventing acid reflux), 
mesh repair (tensionless repair) as opposed to suture cruroplasty (tension repair) for large hiatal hernia 
has been cited as an alternative method for reinforcement of crural pillars thereby decreasing the 
hiatal disruption and preventing wrap migration. However mesh repair itself can be associated with 
early or late complications such as mesh infection, migration, shrinkage and mesh erosion into the 
esophagus or stomach6. Furthermore the fibrotic reaction produced by mesh can make further surgery 
at the esophageal hiatus extremely challenging and hazardous.  
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In order to improve upon the recurrence rate of suture cruroplasty, Carlson et al, in 19997, reported the 
very first randomized controlled trial of laparoscopic prosthetic reinforcement of large hiatal hernia 
with an excellent early outcome. Since then, a number of randomized controlled trials (RCTs)8-14 
comparing suture cruroplasty versus mesh repair of large hiatal hernias have been published, 
analyzing various aspects of these two approaches with conflicting results. The objective of this meta-
analysis was to determine the clinical outcomes, safety and effectiveness of these two methods for 
elective surgical treatment of large hiatal hernias.  
 
MATERIALS AND METHODS: 
Literature Search Strategy, Study Selection and Data Collection 
RCTs were identified by conducting a comprehensive search of electronic databases, PubMed, 
Medline, Embase, Science Citation Index, Current Contents and the Cochrane Central Register of 
Controlled Trials published between January 1991 and October 2014 using medical subject headings 
(MESH); “hernia,” “hiatal,” “hiatus,” “paraoesophageal/paraesophageal hernia,” “laparoscopic 
repair,” “comparative study,” “prospective studies,” “randomized/randomised controlled trial,” 
“random allocation,” ‘clinical trial,” and “Human”. No language restriction was applied. We further 
searched the bibliographies of all the included primary studies and existing reviews by hand for 
additional citations. Data extraction, critical appraisal and quality assessment of the identified studies 
were carried out by two authors (BM, MAM), who also contacted via email the original authors of 
some of the trials for clarification of data and to obtain unpublished, missing or additional information 
on various outcome measures. Only two authors (Carlson MA, , Frantzides CT- personal 
communication) responded to our request and provided further clarification regarding their three 
published RCTs7-9. The authors were not blinded to the source of the document or authorship(s) for 
the purpose of data extraction. Standardized data extraction forms15 were used by authors to 
independently and blindly summarize all the data available in the RCTs. The data that was obtained 
was entered directly into MS Word tables. Double data entry method was used in order to avoid errors 
in data extraction. The data was compared and discrepancies were addressed with discussion until 
consensus was achieved. The analysis was prepared in accordance with the Preferred Reporting of 
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Systematic Reviews and Meta-Analyses (PRISMA) statement16.  Random effects model was used for 
analysis of all the outcome variables.  
 
Eligibility Criteria 
Two reviewers (BM and MAM) individually considered the abstracts of the identified articles for 
eligibility. Appropriateness was determined by these independent reviewers and by discussion in case 
of inconsistency. The RCTs must have reported on at least one clinically relevant outcome pertaining 
to the intraoperative and postoperative period. Outcomes assessed were those considered to exert 
influence over practical aspects of surgical practice and patient management. All studies reporting on 
outcomes of this nature were considered and final analyses were run on outcome variables where 
numbers were sufficient to allow statistical analysis.  
 
Inclusion Criteria 
(i) Type of Study: Only randomized controlled trials published both in full peer-reviewed 
journals and abstract forms between January 1991 and October 2014, were included for 
analysis.  
(ii) Language: No language restriction was applied 
(iii) Type of Intervention: Two different elective laparoscopic approaches for the management of 
large hiatal hernia, namely suture versus prosthetic (non-absorbable and absorbable mesh) 
repair were being assessed for the differences in short and long term surgical outcomes. 
(iv) Type of participants: Adult (>18 years) patients were the target population for this meta-
analysis. 
 
Exclusion Criteria 
(i) Non-randomized controlled trials, duplicated RCTs, unpublished studies and abstracts 
presented at national and international meetings presenting the preliminary data were 
excluded from our analysis. 
(ii) Emergency hiatal hernia surgery 
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Types of Outcome Measures Analyzed 
The four outcome variables analyzed included (a) operative time; (b) complication rate; (c) recurrence 
of hiatal hernia or wrap migration; and (d) reoperation. Other outcome variables such as hospital stay 
could not be analyzed due to inadequate reporting methodology. 
 
Methodological Quality 
The methodological quality of the identified RCTs was assessed using Jadad Scoring system17. Each 
study was allocated a score from zero to five, zero being the lowest quality and five being the highest 
quality based on reporting of randomization, blinding, and withdrawals reported during the study 
period.  
 
Statistical Analysis and Risk of bias across Studies 
Meta-analyses were performed using odds ratios (ORs) for dichotomous outcome and standardized 
mean differences (SMDs) for continuous outcome measures. Data was pooled using the Mantel-
Haenszel and the inverse variance method for dichotomous and continuous outcomes respectively. 
The slightly amended estimator of OR was used to avoid the computation of reciprocal of zeros 
among observed counts in the calculation of the original OR18. DerSimonian and Laird random effects 
model was used to combine the summary data19. This is because in clinical practice, differences in 
patient demographics, health care practitioner skills etc render the assumptions of the fixed effects 
model void when evaluating therapeutic or clinical interventions. Heterogeneity among studies was 
calculated using the Q statistic proposed by Cochran and I2 index introduced by Higgins and 
Thompson19-23. If the observed value of Q was greater than the associated x2 critical value at a given 
significant level, in this case 0.05, we conclude the presence of statistical significance between-studies 
variation. In order to pool continuous data, mean and standard deviation of each study is required. 
However, some of the published clinical trials did not report the mean and standard deviation, but 
rather reported the size of the trial, the median and interquartile range. Using these available statistics, 
estimates of the mean and standard deviation were obtained using formulas proposed by Hozo et al24. 
Funnel plots were produced in order to determine the presence of publication bias in the present meta-
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analysis. Both total sample size and precision (reciprocal of standard error) were plotted against the 
treatment effects (OR for dichotomous variables and SMD for continuous variables)19,25-27. All 
estimates were obtained using a computer program written in R28. All plots were obtained using the 
metafor-package29. In the case of tests of hypotheses, the paper reports p-values for different statistical 
tests on the study variables. In general, the effect is considered to be statistically significant if the p-
value is small. If one uses a 5% significance level then the effect is significant only if the associated 
p-value is ≤5%. 
 
RESULTS: 
Included Studies 
Cross searching of electronic databases yielded a total of 101 abstracts and hand searches of reference 
lists provided a further 6 citations. After exclusion of non-relevant citations, 39 unique citations of 
potential relevance were retrieved for review. The process by which these citations were excluded is 
described in Figure 1. There was almost perfect agreement (κ=0.99) between two authors (BM and 
MAM) regarding inclusion of these RCTs. No further potentially relevant unpublished studies were 
identified through a citation search of previous published reviews on this subject. It is to be noted that 
no previous meta-analysis on this subject has been published to date. Eight RCTs met the inclusion 
criteria7-14. Of these, several involved the presentation of data derived from the same cohort of patients 
at different follow-up times7-13. This was particularly relevant to longer-term outcome measures such 
as treatment failure and re-operation rates. For the purpose of accurate statistical analysis and 
consistency of data compiling, in the aforementioned instances we considered all the data derived 
from a particular cohort of patients as being a single trial event. This reduced the apparent number of 
included trials to four (Figure 1, Table 1). As no language restriction was applied, no RCT published 
on this subject was excluded from our meta-analysis. 
 
Methodological Quality 
In general, the quality of RCTs  demonstrated poor methodological quality based on Jadad score with 
an average score of 1.7 (out of five), with a range of 1 to 3 (Table 1). Only one study reported on 
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withdrawals and drop-outs14, two described an appropriate method of randomization10,14, whereas only 
one of the trials reported on the single blinding of the patients14 (Table 1). 
 
Heterogeneity 
The Q test and I2 Index are commonly used methods in meta-analysis for detecting heterogeneity. 
Significant heterogeneity i.e. I2 index of 50% or more22,30 was only present for operating time 
(Q=14.83, p= <0.0006, I2= 88.53, CI=55.44, 99.72) (Table 2). 
 
Publication Bias 
Only one of the funnel plots belonging to operating time demonstrate asymmetry and thus suggest the 
presence of publication bias. Other funnel plots belonging to recurrence of hiatal hernia/wrap 
migration, reoperation rate and complication failed to show publication bias. However the number of 
studies included for all these variables were too few to sensitively detect publication bias (Fig 2). 
 
Clinical Outcomes  
Four RCTs (USA = 3, Australia = 1) were analyzed. For only one of the four outcomes i.e. 
reoperation rate (OR 3.73, 95% CI 1.18, 11.82, p=0.02) (Fig 2) the effect size estimate favored 
prosthetic hiatal herniorrhaphy over suture cruroplasty. For other outcomes, comparable effects were 
noted for both groups which included recurrence of hiatal hernia or wrap migration (OR 2.01, 95% CI 
0.92, 4.39, p=0.07) (Fig 3), operating time (SMD -0.46, 95% CI -1.16, -0.24, p=0.19) (Fig 4) and 
complication rates (OR 1.06, 95% CI 0.45, 2.50, p=0.90) (Fig 5) (Table 2).  
 
Description of various RCTs 
Salient features of various RCTs comparing suture cruroplast versus mesh repair are detailed in Table 
1. The four included studies were published between 2002 and 2014 totaling 406 patients 
(Suture=186, Prosthesis=220). The study size in one9 out of 4 RCTs was less than 100 patients in both 
arms. There were three occasions7-13 where several trials were involved in the presentation of data 
derived from the same cohort of patients at different follow-up times. For the purpose of accurate 
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statistical analysis, we considered all the data derived from a particular cohort of patients as being a 
single trial event. The size of hiatal defect in 3 out of 4 trials9,10,12  was provided in centimeters where 
Watson et al14 defined a very large hiatal hernia as more than 50% of stomach in the chest. 
Postoperative gastroscopy and barium swallow (esophagogram) were undertaken by all the authors7-14 
to determine the hernia recurrence. Detailed evaluation of clinical symptoms such as heartburn and 
dysphagia were subjectively evaluated pre and postoperatively at various time points depending on 
the study protocol by three RCTs10,13,14. However all the RCTs analyzed their data at 6 months. 
Randomized controlled trial by Granderath et al10 is the only trial which provided postoperative 
objective assessment of reflux using 24 hour pH monitoring. Except for Watson et al RCT14 who 
undertook laparoscopic partial fundoplication for the vast majority of their patients (anterior partial = 
107, posterior partial = 17), the rest of the RCTs undertook hiatal repair in conjunction with 
laparoscopic Nissen fundoplication. The definition of recurrent hernia was either missing in some 
trials9,10 whereas in the others, it varied according to the authors’ preference12,14.  
 
DISCUSSION: 
Because of a substantial failure rate of between 12% to 42%4,5  with suture cruroplasty during the 
early days of laparoscopic antireflux surgery, a number of authors started experimenting with the use 
of mesh to improve the operative results in terms of recurrent hiatal disruption and wrap migration. 
The very first RCT reporting excellent early outcomes for large hiatal hernia with non-absorbable 
prosthesis was reported by Carlson et al7. The longitudinal data involving a larger cohort of patients 
was subsequently reported by Frantzides et al9. The authors reported 22% rate of recurrent hiatal 
hernia in the suture cruroplasty group compared to 0% in non-absorbable hiatal herniorrhapy utilizing 
endoscopy and barium swallow study at a mean follow-up of 3.3 years. All recurrences occurred 
within the first 6 months. However what constituted recurrence on oesophagogram is not clear as no 
precise definition is provided. Five patients underwent further surgery and placement of PTFE mesh 
to close the hiatal defect in the suture cruroplasty group. The other three patients refused surgery and 
were treated medically. No complications related to mesh such as erosion, stricture or infection have 
been observed by these authors.  
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Granderath et al10 published another RCT analyzing 100 patients undergoing laparoscopic Nissen 
fundoplication along with either simple suture cruroplasty or non-absorbable polypropylene mesh 
placement for closure of hiatal defect either 5 cm or > 5 cm at 12 months follow-up. A higher 
postoperative dysphagia rate was observed in the prosthetic group at 6 weeks and 3 months which 
seems to have disappeared at 1 year follow-up10. In both groups 24 hour ambulatory pH study showed 
a significant reduction in DeMeester score postoperatively at 1 year compared to preoperative score. 
An intrathoracic wrap migration occurred in 13 patients in the simple cruroplasty group compared to 4 
in the prosthetic group. Once again the precise nature of wrap migration is missing and furthermore 
whether this intrathroacic migration was partial or complete is also lacking.  All four patients in the 
prosthetic group with hernia recurrence underwent laparoscopic redo surgery. No such information is 
available on 13 patients in the suture cruroplasty group who had recurrent hernias.  
 
A multicenter RCT conducted by Oelschager et al12 evaluating the use of biologic prosthesis for repair 
of large paraesophageal hernia in 108 patients was reported in 2005. The definition of recurrent hiatal 
hernia was based on upper gastrointestinal imaging of hiatal hernia > 2 cm or need for reoperation 
secondary to wrap disruption, migration or herniation at any time during the study period. This trial 
reported a 9% rate of recurrent hiatal hernia in the biologic prosthetic group compared to 24% in the 
suture cruroplasty group at 6 month follow-up. However at a median follow-up of 58 months 
analyzing the same cohort of 72 patients13, the recurrence rate in both groups was similar; 59% in the 
suture cruroplasty group and 54% in the biologic prosthetic group. No statistical significant difference 
was noted in terms of relevant symptoms or quality of life issues between the two groups. No mesh 
related complications were seen with biologic mesh. The authors of this study concluded that the 
benefit of biologic prosthesis in reducing hiatal hernia recurrence diminishes at long-term follow-up. 
These authors emphasized the validity of their results based on the following facts; (a) the objective 
manner of detecting postoperative recurrence by a blinded third party i.e. radiologists and (b) the 
participation of experienced laparoscopic surgeons from high volume esophageal surgical centers. 
However they conceded that strict criteria used to diagnose the recurrence may have overestimated 
the recurrence rate. Nonetheless, the authors of this study feel that the biologic mesh, although may 
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not protect against recurrent hiatal hernias, it may reduce the risk of severe hernias leading to fewer 
reoperations as evident in their study. They also felt that compared to non-absorbable mesh with its 
known complications such as erosion into adjacent structures e.g. esophagus or stomach which leads 
to severe dysphagia, the biologic mesh has no long-term negative consequences. 
 
A recent randomized controlled trial14 assessing the role of absorbable (n=41) and non-absorable 
mesh (n=42) versus simple suture repair (n=43) of large hiatal hernia containing 50% of stomach in 
the chest showed no significant difference in hernia recurrence between suture cruroplasty versus 
prosthetic hiatal herniorrhaphy when assessed objectively by barium swallow and endoscopy at 12 
months. The definition of recurrence included any evidence of stomach above the level of the 
diaphragm, irrespective of the size. The recurrence rate of 23.1% was observed in suture pair, 30.8% 
after absorbable mesh repair and 12.8% after non-absorbable mesh repair. Clinical outcomes were 
more or less similar between these three groups. Three patients in the suture group required early 
laparoscopic reintervention for acute hiatal hernia and another patient required revision surgery at 7 
months. This is in comparison to the non-absorbable mesh group in whom 1 early recurrence was 
observed and no recurrence was seen in the absorbable mesh group. These results may change with 
more extended follow-up at 24, 36 and 60 months as seen with other clinical trials13. The result of the 
above study are in total contrast to all other RCTs reporting favorable short-term outcome of hiatal 
hernia repair with prosthesis, both biologic and non-absorbable (Table 4).  
 
The pooled effect size on recurrent hiatal hernia in our meta-analysis did not show any difference in 
the hiatal recurrence between suture cruroplasty and prosthetic hiatal herniorrhaphy (OR 2.01, 95% CI 
0.92, 4.39, p=0.07) (Fig 3), although the trend was favoring the latter group. As none of the RCTs 
except for the one by Oelschlager et al13 have provided long term follow-up data to date, the true 
recurrent rate of hiatal hernia between the two groups may diverge with passage of time especially in 
the non-absorbable prosthetic group. Only long term longitudinal studies will clarify this issue. 
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The second variable which was closely aligned with hiatal hernia recurrence or wrap migration was 
reoperation rate (Table 5). In Frantzides et al study9 5 out of 8 patients in the suture cruroplasty group 
underwent further surgery and placement of PTFE mesh to close the hiatal defect. In Granderath et al 
RCT10 although there was statistically significant intrathoracic wrap migration in the suture 
cruroplasty group (13 patients) versus the prosthetic mesh repair group (4 patients), the authors have 
provided reoperation details of 4 patients in the latter group, two of whom had further circular hiatal 
mesh placement. No such information is available regarding the fate of 13 patients in the suture 
cruroplasty group. In Oelschlager et al13 long term follow-up (median 58 months) study, only two 
patients required surgery in the suture cruroplasty group whereas none in the biologic prosthetic 
group.  Lastly Adelaide’s RCT14 revealed 4 revisional surgeries in the suture cruroplasty group within 
30 days for (a) tight hiatal repair (n=1), (b) acute hiatal hernia (n=3) and one at 7 months for recurrent 
hiatal hernia (n=1). In the prosthetic mesh group, no surgery was required in the absorbable mesh 
group whereas 3 revisional surgeries occurred within 30 days for (a) tight hiatal repair (n=2) and acute 
hiatal hernia and gastric perforation (n=1). One reoperation was carried out at 8 months for persistent 
dysphagia.  
 
The pooled data on reoperation in our meta-analysis showed significant higher risk of revisional 
surgery following suture cruroplasty compared to prosthetic hiatal herniorrhaphy (OR 3.79, 95% CI 
1.20, 11.99, p=0.02) (Fig 4). The peril of reoperation cannot be underestimated as it carries higher risk 
of morbidity and mortality due to complex subsequent procedure, longer duration of operation, 
lengthy postoperative stay and higher cost to patients and insurers.  
 
The operating time was reported by all the RCTs9,10,12,14 (Table 6). However due to lack of availability 
of standard deviation in Granderath et al10, their data was excluded for analysis. Only Frantzides et al9 
showed significantly longer operating time for the prosthetic hiatal herniorrhaphy group compared to 
the suture cruroplasty group. The other three RCTs10,12,14 did not show significant difference in mean 
operating times for the two groups (Table 6). The pooled effect size showed comparable results for 
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both groups (SMD -0.46, 95% CI 1.16, 0.24, p=0.1990) (Fig 5). Longer operating times in the earlier 
trials may in part reflect an initial learning curve for laparoscopic prosthetic hiatal herniorrhaphy . 
 
As far as the complication rate of suture cruroplast versus prosthetic hiatal herniorrhaphy is 
concerned, the present analysis showed no difference in the incidence of postoperative complications 
between the two groups  (Table 2, Fig. 5). Once again due to lack of long term data for three out of 
four RCTs9,10,14, accurate assessment of this variable cannot be determined. One of the dangers of 
hiatal reinforcement with non-absorbable mesh, is the risk of its erosion into the adjacent structures 
such as esophagus or stomach which in turn can lead to severe dysphagia6,31,32. This had not been 
observed with biologic mesh as reported by Oelschlager et al13. Once the long term data for all these 
RCTs becomes available the true incidence of complications of different types of prosthesis for hiatal 
closure will become clearer.   
 
LIMITATIONS:  
There are a number of limitations both statistical and clinical in this paper. Firstly, the small number 
of studies included in this meta-analysis remains a largely unavoidable limitation of this and many 
other meta-analyses conducted in surgical fields33. Secondly, some degree of between-study 
heterogeneity was detected, which may undermine the quality and legitimacy of the results obtained33. 
However in this meta-analysis, the heterogeneity was only detected in one variable. Thirdly, use of 
different types of prosthetic meshes i.e. both absorbable and non-absorbable for repair of hiatal hernia 
may be a potential limitation. Fourthly, definition of what constitutes a large hiatal hernia varies 
between different RCTs. Fifth, there is no standardized definition of recurrent hiatal hernia between 
various RCTs. Lastly, as the follow-up for most of these RCTs9,10,14 except for one12 has been short, 
the true incidence of recurrence of hiatal hernia and redo surgery are not truly known and therefore 
the results of any short term or medium term benefits especially of prosthetic hiatal herniorrhaphy 
needs to be interpreted with extreme caution.  
 
CONCLUSIONS: 
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On the basis of this meta-analysis and its limitations, we believe that prosthetic hiatal herniorrhaphy 
and suture cruroplasty produces comparable results for repair of large hiatal hernias. In the future a 
number of issues need to be addressed to determine the clinical outcomes, safety and effectiveness of 
these two methods for elective surgical treatment of large hiatal hernias. These include (i) 
standardized definition of large hiatal hernia; (ii) standardized techniques of suture and prosthetic 
repair; (iii) type of prosthesis used – biologic versus non-absorbable; (iv) standardized method of 
securing the mesh such as use of sutures, tacks or biologic glues; (v) standardized classification of 
recurrent hiatal hernia post repair; (vi) standardized method of detecting recurrence e.g. gastroscopy, 
barium swallow or CT; (vii) objective assessment of recurrent hiatal hernia via 24 hour ambulatory 
impedance pH monitoring and lastly (viii) long term postoperative data collection of at least 5 years to 
detect the true incidence of hiatal hernia recurrence between suture cruroplasty and prosthetic hiatal 
herniorrhaphy. Until all the above mentioned issues are clarified, the routine use of prosthetic hiatal 
herniorrhaphy for large hiatal hernia cannot be endorsed routinely and the decision for the placement 
of mesh needs to be individualized based on the operative findings and the surgeon’s 
recommendation.  
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FIGURE LEGENDS: 
Figure 1: PRISMA flow diagram 
Figure 2: Forrest plot for reoperation 
Figure 3: Forrest plot for recurrence of hiatal hernia or wrap migration 
Figure 4: Forrest plot for operating time 
Figure 5: Forrest plot for complications 
